16.92
Precedente Chiudi:
$18.37
Aprire:
$18.67
Volume 24 ore:
319.99K
Relative Volume:
17.74
Capitalizzazione di mercato:
$761.05M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Maplight Therapeutics Inc Stock (MPLT) Company Profile
Nome
Maplight Therapeutics Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MPLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MPLT
Maplight Therapeutics Inc
|
16.92 | 761.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Maplight Therapeutics Inc Borsa (MPLT) Ultime notizie
MapLight Therapeutics, Inc. (MPLT) Stock Major Holders - Yahoo! Finance Canada
Finance Watch: MapLight Brings US Biopharma IPO Tally To 11 In 2025 - Citeline News & Insights
MapLight Therapeutics Closes Successful IPO and Private Placement - MSN
Major Investment Alert: A S Novo’s Multi-Million Dollar Bet on MapLight Therapeutics! - TipRanks
Drug developer Evommune to go public next week, following MapLight's successful IPO - The Business Journals
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN
MapLight Therapeutics completes $296 million IPO on nasdaq - Investing.com
Catalyst4, Inc. Makes a Major Move with a Massive Stock Purchase in MapLight Therapeutics! - TipRanks
MapLight Therapeutics, Inc. (MPLT) Latest Stock News & Headlines - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Stock Forum & Discussion - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Interactive Stock Chart - Yahoo! Finance Canada
MapLight Therapeutics completes $296 million IPO on nasdaq By Investing.com - Investing.com Nigeria
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Total liabilities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted earnings per share (diluted EPS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Revenue Breakdown – NASDAQ:MPLT - TradingView
Total liabilities & shareholders' equities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Net debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating expenses (excl. COGS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Taxes of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Financial Statements – NASDAQ:MPLT - TradingView
Total revenue of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total operating expenses of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Gross profit of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
After tax other income/expense of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Earnings and Revenue – NASDAQ:MPLT - TradingView
EBITDA margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Balance Sheet – NASDAQ:MPLT - TradingView
Non-controlling/minority interest of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Muscarinic path still charting as Maplight IPO gets $258M - BioWorld MedTech
MapLight Therapeutics, Inc. Income Statement – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Statistics – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. (MPLT) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Company Profile & Facts - Yahoo! Finance Canada
MPLT: Static price chart | MapLight Therapeutics, Inc. | US56565P1030 - MarketScreener
MapLight Therapeutics announces pricing of IPO - The Pharma Letter
Sergey Brin nonprofit gets $261 million lift in MapLight IPO - Crain Currency
MapLight shares track up after $251m IPO - pharmaphorum
MapLight Therapeutics, Inc. (MPLT) Options Chain - Yahoo! Finance Canada
Latham & Watkins Advises on MapLight Therapeutics’ Initial Public Offering - Legal Desire Media and Insights
MapLight Therapeutics, Inc.(NasdaqGS: MPLT) added to NASDAQ Composite Index - MarketScreener
MapLight Therapeutics Inc. (MPLT): Oversubscribed Neuroscience IPO Launches with a Bright Start - Smartkarma
Sergey Brin Nonprofit Gets a $242 Million Lift From MapLight IPO - Bloomberg.com
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO (2) - Bloomberg Law News
Biotech MapLight Jumps 23% in First US IPO Using Shutdown Fix - Bloomberg.com
Biotech Firm MapLight Inks $251M IPO Amid Shutdown - Law360
MapLight Therapeutics raises $258M in IPO, private placement - Axios
CNS drug developer MapLight goes public, stock up 9% on first day of trading - The Business Journals
Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut - Yahoo Finance
Maplight Therapeutics Inc Azioni (MPLT) Dati Finanziari
Non sono disponibili dati finanziari per Maplight Therapeutics Inc (MPLT). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):